Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

746
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
746
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

511
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Promoting Brain Health in the Context of Normal Aging and Mild Cognitive Impairment: A Tutorial.

American journal of speech-language pathology·2026
Same author

The collection of speech data for the assessment of cognition remotely: Balancing ethical and practical challenges.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Visuospatial Working Memory Predicts Strategic Motor Learning With Visual Feedback During Gait After Stroke.

Neurorehabilitation and neural repair·2026
Same author

Multiecho Fat-Water Spiral MR Elastography With Distributed Encoding for Simultaneously Imaging Brain and Skull Displacement.

Magnetic resonance in medicine·2026
Same author

The Influence of Blood Lipids on Cerebral Perfusion by Apolipoprotein E Status.

Journal of lipid research·2026
Same author

Mechanical properties of the developing brain in a model of fetal alcohol spectrum disorders and relationships to perineuronal net integrity.

Brain research·2026
Same journal

Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Human brain connectome profiles mediate the relationship between pathology burden and clinical phenotypes in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Kat5 cKO mouse replicates biological domain signatures associated with Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Associations of self-reported obstructive sleep apnea with cognition and dementia risk in cognitively unimpaired middle-aged adults.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Inflammation profiles in Alzheimer's disease relate to cognition and neurodegeneration.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
See all related articles

Related Experiment Video

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

Biomarkers.

Mary K Kramer1, Nicholas J Pyontek1, Nicholas A Rizzi1

  • 1University of Delaware, Newark, DE, USA.

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|December 25, 2025
PubMed
Summary
This summary is machine-generated.

Magnetic Resonance Elastography (MRE) reveals reduced brain stiffness correlating with Alzheimer's disease (AD) biomarkers in asymptomatic individuals. This suggests MRE can detect early AD-related mechanical changes using accessible blood tests.

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

Related Experiment Videos

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

Area of Science:

  • Neuroscience
  • Biomarker Discovery
  • Medical Imaging

Background:

  • Alzheimer's Disease (AD) pathology, including amyloid and tau accumulation, can be present in asymptomatic individuals, representing a critical window for intervention.
  • Magnetic Resonance Elastography (MRE) quantifies brain tissue stiffness, offering a method to detect early microstructural changes associated with AD.
  • The hippocampus and entorhinal cortex (ERC) are key regions affected early in AD pathology.

Purpose of the Study:

  • To investigate the relationship between brain mechanical properties measured by MRE and plasma-based Alzheimer's Disease (AD) biomarkers.
  • To determine if MRE can detect early microstructural changes in the hippocampus and ERC in individuals with elevated AD risk.

Main Methods:

  • Twelve participants from the Delaware Longitudinal Study for Alzheimer's Prevention underwent neuropsychological testing, bloodwork, and MRE.
  • Plasma amyloid-beta (Aβ) and phosphorylated tau (pTau-181, pTau-217) were quantified using Single Molecule Array (Simoa) assays.
  • MRE measured the stiffness of the hippocampus and entorhinal cortex (ERC).

Main Results:

  • Hippocampal stiffness inversely correlated with plasma pTau-181 and Aβ40 levels.
  • ERC stiffness showed a similar inverse correlation with pTau-181 and a near-significant correlation with pTau-217.
  • Individuals with lower AD biomarker concentrations exhibited higher stiffness in the hippocampus and ERC, indicating a link between biomarker levels and brain tissue degradation.

Conclusions:

  • This study is the first to link brain mechanical properties measured by MRE with plasma-based AD biomarkers.
  • Reduced stiffness in the hippocampus and ERC suggests microstructural disruption due to protein accumulation.
  • MRE measures show sensitivity to the impact of protein aggregates on brain mechanics, supporting its use in early AD detection alongside accessible blood biomarkers.